The structural maintenance of chromosomes 5 is a possible biomarker for individualized treatment of colorectal cancer

BACKGROUND: Although the understanding of resistance to oxaliplatin (OXA) chemotherapy in colorectal cancer (CRC) has been sought for many years, drug tolerance remains a major challenge for cancer therapy. Revealing the molecular mechanism of OXA resistance could help to explain the poor prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Xiaoxia, Tian, Xiaowei, Xie, Hao, Li, Zhaoshui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939147/
https://www.ncbi.nlm.nih.gov/pubmed/35894836
http://dx.doi.org/10.1002/cam4.5074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939147/
https://www.ncbi.nlm.nih.gov/pubmed/35894836
http://dx.doi.org/10.1002/cam4.5074

Ejemplares similares